533 related articles for article (PubMed ID: 9989983)
1. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
[TBL] [Abstract][Full Text] [Related]
2. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.
Ward AC; van Aesch YM; Schelen AM; Touw IP
Blood; 1999 Jan; 93(2):447-58. PubMed ID: 9885206
[TBL] [Abstract][Full Text] [Related]
3. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
4. Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice.
Mitsui T; Watanabe S; Taniguchi Y; Hanada S; Ebihara Y; Sato T; Heike T; Mitsuyama M; Nakahata T; Tsuji K
Blood; 2003 Apr; 101(8):2990-5. PubMed ID: 12672695
[TBL] [Abstract][Full Text] [Related]
5. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
Dong F; Qiu Y; Yi T; Touw IP; Larner AC
J Immunol; 2001 Dec; 167(11):6447-52. PubMed ID: 11714811
[TBL] [Abstract][Full Text] [Related]
8. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
Hunter MG; Jacob A; O'donnell LC; Agler A; Druhan LJ; Coggeshall KM; Avalos BR
J Immunol; 2004 Oct; 173(8):5036-45. PubMed ID: 15470047
[TBL] [Abstract][Full Text] [Related]
9. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
Dror Y; Ward AC; Touw IP; Freedman MH
Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
[TBL] [Abstract][Full Text] [Related]
10. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
Germeshausen M; Ballmaier M; Welte K
Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
[TBL] [Abstract][Full Text] [Related]
11. Severe congenital neutropenia terminating in acute myeloid leukemia: disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene.
Touw IP; Dong F
Leuk Res; 1996 Aug; 20(8):629-31. PubMed ID: 8913314
[TBL] [Abstract][Full Text] [Related]
12. The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease.
Ward AC
Front Biosci; 2007 Jan; 12():608-18. PubMed ID: 17127322
[TBL] [Abstract][Full Text] [Related]
13. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
Ward AC; van Aesch YM; Gits J; Schelen AM; de Koning JP; van Leeuwen D; Freedman MH; Touw IP
J Exp Med; 1999 Aug; 190(4):497-507. PubMed ID: 10449521
[TBL] [Abstract][Full Text] [Related]
14. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.
Grenda DS; Johnson SE; Mayer JR; McLemore ML; Benson KF; Horwitz M; Link DC
Blood; 2002 Nov; 100(9):3221-8. PubMed ID: 12384420
[TBL] [Abstract][Full Text] [Related]
15. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
Qiu Y; Zhuang D; MacRae A; Dong F
Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
[TBL] [Abstract][Full Text] [Related]
16. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.
Dong F; Hoefsloot LH; Schelen AM; Broeders CA; Meijer Y; Veerman AJ; Touw IP; Löwenberg B
Proc Natl Acad Sci U S A; 1994 May; 91(10):4480-4. PubMed ID: 7514305
[TBL] [Abstract][Full Text] [Related]
17. Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia.
Hermans MH; Ward AC; Antonissen C; Karis A; Löwenberg B; Touw IP
Blood; 1998 Jul; 92(1):32-9. PubMed ID: 9639496
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.
Ward AC; Hermans MH; Smith L; van Aesch YM; Schelen AM; Antonissen C; Touw IP
Blood; 1999 Jan; 93(1):113-24. PubMed ID: 9864153
[TBL] [Abstract][Full Text] [Related]
19. G-CSF receptor mutations in patients with severe congenital neutropenia do not abrogate Jak2 activation and stat1/stat3 translocation.
Herbst A; Koester M; Wirth D; Hauser H; Welte K
Ann N Y Acad Sci; 1999 Apr; 872():320-5; discussion 325-7. PubMed ID: 10372134
[TBL] [Abstract][Full Text] [Related]
20. Myeloid development is selectively disrupted in PU.1 null mice.
Anderson KL; Smith KA; Conners K; McKercher SR; Maki RA; Torbett BE
Blood; 1998 May; 91(10):3702-10. PubMed ID: 9573007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
